Healthcare
1058 companies in this sector
Insider Buys (30d)
90
$252.31M
Insider Sells (30d)
527
$2.12B
Monthly Insider Volume
Industries
Biotechnology601 companies
Medical - Devices131 companies
Drug Manufacturers - Specialty & Generic64 companies
Medical - Instruments & Supplies51 companies
Medical - Diagnostics & Research49 companies
Medical - Care Facilities47 companies
Medical - Healthcare Information Services41 companies
Medical - Pharmaceuticals21 companies
Drug Manufacturers - General20 companies
Medical - Healthcare Plans12 companies
Medical - Specialties10 companies
Medical - Distribution8 companies
Medical - Equipment & Services3 companies
Top Companies by Market Cap
Recent Insider Trades
| Date | Ticker | Company | Insider | Role | Type | Shares | Avg Price | Value |
|---|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | PYXS | Pyxis Oncology, Inc. | GordonMD Global Investments LP | 10 percent owner | Buy | 7,172,000 | $3.50 | $25.10M |
| Oct 9, 2026 | MASS | 908 Devices Inc. | Brown Christopher D. | director | Sell | 30,000 | $11.89 | $356.7K |
| Oct 9, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,300 | $534.50 | $4.97M |
| Oct 9, 2026 | IMVT | Immunovant, Inc. | Van Tuyl Christopher | officer: Chief Legal Officer | Sell | 1,327 | $32.06 | $42.5K |
| Oct 9, 2026 | PTCT | PTC Therapeutics, Inc. | SCHMERTZLER MICHAEL | director | Sell | 2,500 | $63.39 | $158.5K |
| Oct 9, 2026 | IMVT | Immunovant, Inc. | Gloria Melanie | officer: Chief Operating Officer | Sell | 2,241 | $32.06 | $71.8K |
| Oct 9, 2026 | IMVT | Immunovant, Inc. | Stout Jay S | officer: Chief Technology Officer | Sell | 3,809 | $32.06 | $122.1K |
| Oct 9, 2026 | ZYME | Zymeworks Inc. | Schayowitz Adam | officer: EVP, Head of R&D | Sell | 13,832 | $25.85 | $357.6K |
| Oct 9, 2026 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | officer: Senior Vice President, Finance | Sell | 6,000 | $36.32 | $217.9K |
| Oct 9, 2026 | NEOG | Neogen Corporation | Nassif Mikheal | director, officer: CEO | Buy | 505 | $11.95 | $6.0K |
| Oct 9, 2026 | ONMD | OneMedNet Corporation | Green Aaron | director, officer: Chief Executive Officer | Sell | 6,667 | $7.16 | $47.8K |
| Oct 9, 2026 | ONMD | OneMedNet Corporation | Golden Robert Lawrence | director, officer: Chief Financial Officer | Sell | 8,500 | $6.50 | $55.3K |
| Oct 8, 2026 | PACB | Pacific Biosciences of California, Inc. | Gibson James R II | officer: See Remarks | Sell | 661,815 | $3.11 | $2.06M |
| Oct 8, 2026 | EW | Edwards Lifesciences Corporation | Lippis Daniel J. | officer: CVP, TAVR | Sell | 619 | $85.65 | $53.0K |
| Oct 8, 2026 | RAPP | Rapport Therapeutics, Inc. Common Stock | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 4,522 | $31.68 | $143.3K |
| Oct 8, 2026 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | director, officer: President and CEO | Sell | 48,199 | $18.10 | $872.4K |
| Oct 8, 2026 | RMD | ResMed Inc. | Farrell Michael J. | director, officer: Chairman and CEO | Sell | 4,991 | $226.33 | $1.13M |
| Oct 8, 2026 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | officer: Chief Financial Officer | Sell | 17,717 | $18.59 | $329.3K |
| Oct 8, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $548.95 | $5.22M |
| Oct 8, 2026 | NRXS | NeurAxis, Inc. | Carrico Brian Allen | director, officer: Chief Executive Officer | Buy | 268 | $4.84 | $1.3K |
| Oct 8, 2026 | BFLY | Butterfly Network, Inc. | DEVIVO JOSEPH | director, officer: President & CEO | Sell | 35,790 | $10.02 | $358.6K |
| Oct 8, 2026 | NRXS | NeurAxis, Inc. | Henrichs Timothy Robert | officer: Chief Financial Officer | Buy | 1,937 | $4.84 | $9.4K |
| Oct 8, 2026 | NRXS | NeurAxis, Inc. | Carrico Thomas Joeseph | officer: CRO, CCO, CPO | Buy | 328 | $4.84 | $1.6K |
| Oct 8, 2026 | MASS | 908 Devices Inc. | Griffith Joseph H. IV | officer: Chief Financial Officer | Sell | 5,000 | $13.03 | $65.2K |
| Oct 8, 2026 | IDYA | IDEAYA Biosciences, Inc. | Hata Yujiro S | director, officer: President and CEO | Sell | 26,338 | $37.41 | $985.4K |
| Oct 8, 2026 | AVR | Anteris Technologies Global Corp. | L1 Capital Pty Ltd | 10 percent owner | Buy | 272,695 | $7.18 | $1.96M |
| Oct 8, 2026 | ADPT | Adaptive Biotechnologies Corporation | BOBULSKY SUSAN | officer: Chief Commercial Officer, MRD | Sell | 6,444 | $30.00 | $193.3K |
| Oct 8, 2026 | ADPT | Adaptive Biotechnologies Corporation | RUBINSTEIN JULIE | officer: President and COO | Sell | 35,643 | $26.60 | $948.2K |
| Oct 8, 2026 | HALO | Halozyme Therapeutics, Inc. | Torley Helen | director, officer: PRESIDENT AND CEO | Sell | 60,000 | $110.18 | $6.61M |
| Oct 7, 2026 | LQDA | Liquidia Corporation | Bloch Stephen M | director | Sell | 235,477 | $27.13 | $6.39M |
| Oct 7, 2026 | DNA | Ginkgo Bioworks Holdings, Inc. | Coen Steven P. | officer: See remarks | Sell | 2,403 | $15.00 | $36.0K |
| Oct 7, 2026 | RXRX | Recursion Pharmaceuticals, Inc. | Borgeson Blake | director | Sell | 50,000 | $4.84 | $242.0K |
| Oct 7, 2026 | GRAL | GRAIL Inc. | Partridge Andrew John | officer: Chief Growth Officer | Sell | 7,873 | $146.39 | $1.15M |
| Oct 7, 2026 | GKOS | Glaukos Corporation | Navratil Tomas | officer: CHIEF DEVELOPMENT OFFICER | Sell | 1,527 | $164.45 | $251.1K |
| Oct 7, 2026 | RXRX | Recursion Pharmaceuticals, Inc. | HERSHBERG ROBERT | director | Sell | 25,000 | $5.00 | $125.0K |
| Oct 7, 2026 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | director, officer: See Remarks | Sell | 58,333 | $12.92 | $753.9K |
| Oct 7, 2026 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | director, officer: Chief Executive Officer | Sell | 23,463 | $7.20 | $168.9K |
| Oct 7, 2026 | ALHC | Alignment Healthcare, Inc. | Kim Hyong | officer: Chief Medical Officer | Sell | 32,479 | $8.30 | $269.6K |
| Oct 7, 2026 | CSTL | Castle Biosciences, Inc. | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | Sell | 14,496 | $35.57 | $515.6K |
| Oct 7, 2026 | EBS | Emergent BioSolutions Inc. | DeGolyer Donald W | director | Sell | 17,800 | $7.09 | $126.2K |
| Oct 7, 2026 | WAY | Waystar Holding Corp. | Hawkins Matthew J. | director, officer: Chief Executive Officer | Sell | 82,500 | $26.23 | $2.16M |
| Oct 7, 2026 | IRIX | IRIDEX Corporation | Lin Shih-Yao David | 10 percent owner | Buy | 1,186,809 | $1.10 | $1.31M |
| Oct 7, 2026 | GRAL | GRAIL Inc. | Freidin Aaron | officer: Chief Financial Officer | Sell | 23,619 | $146.39 | $3.46M |
| Oct 7, 2026 | BLLN | BillionToOne, Inc. | Tsao David | director, officer: Chief Technology Officer | Sell | 20,000 | $108.15 | $2.16M |
| Oct 7, 2026 | CRL | Charles River Laboratories International, Inc. | Parisotto Shannon M | officer: CEVP, Disc & Safety Assessment | Sell | 981 | $308.44 | $302.6K |
| Oct 7, 2026 | TLSI | TriSalus Life Sciences, Inc. | Cox Bryan F. | officer: Chief of Research | Sell | 296 | $4.39 | $1.3K |
| Oct 7, 2026 | PACS | PACS Group, Inc. | Murray Jason Hulse | director, 10 percent owner, officer: Co-Founder, CEO & Chairman | Sell | 36,692 | $43.08 | $1.58M |
| Oct 7, 2026 | PCVX | Vaxcyte, Inc. | Wassil Jim | officer: EVP, Chief Scientific Ofc, COO | Sell | 18,000 | $86.74 | $1.56M |
| Oct 7, 2026 | CLOV | Clover Health Investments, Corp. | Reynoso Jamie L. | officer: CEO, Medicare Advantage | Sell | 2,006 | $4.63 | $9.3K |
| Oct 7, 2026 | TWST | Twist Bioscience Corporation | Leproust Emily M. | director, officer: Chief Executive Officer | Sell | 4,548 | $202.15 | $919.4K |
Showing 1–50 of 500
1 / 10
...